RetinAI Discovery® UNITY is designed to improve the healthcare decision process in Ophthalmology. It is one platform for unification and structuring of data in a single ecosystem.
By unlocking the power of data, Discovery UNITY helps pharmaceutical and life sciences build unparalleled disease understanding to help guide and accelerate research and development for better patient care.
RetinAI Discovery® and the AI models are CE-Marked medical devices according to the Medical Devices Directive 93/42/EEC.
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.
AI Models are CE-Marked medical devices since December 2020 & April 2021.